KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Zimmer Biomet Holdings (ZBH) Cash from Operations (2016 - 2026)

Zimmer Biomet Holdings has reported Cash from Operations over the past 18 years, most recently at 359400000.0 for Q1 2026.

For Q1 2026, Cash from Operations fell 6.11% year-over-year to 359400000.0; the TTM value through Mar 2026 reached 1673700000.0, up 1.18%, while the annual FY2025 figure was 1697100000.0, 13.19% up from the prior year.
Cash from Operations for Q1 2026 was 359400000.0 at Zimmer Biomet Holdings, down from 517400000.0 in the prior quarter.
Over five years, Cash from Operations peaked at 588400000.0 in Q4 2023 and troughed at 228000000.0 in Q1 2024.
A 5-year average of 381982352.94 and a median of 369400000.0 in 2024 define the central range for Cash from Operations.
Biggest five-year swings in Cash from Operations: fell 27.67% in 2022 and later skyrocketed 140.95% in 2023.
Year by year, Cash from Operations stood at 244200000.0 in 2022, then skyrocketed by 140.95% to 588400000.0 in 2023, then decreased by 13.95% to 506300000.0 in 2024, then increased by 2.19% to 517400000.0 in 2025, then plummeted by 30.54% to 359400000.0 in 2026.
Business Quant data shows Cash from Operations for ZBH at 359400000.0 in Q1 2026, 517400000.0 in Q4 2025, and 418700000.0 in Q3 2025.